Updated Jul 16, 2026
Matheis Dennis has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $347K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | LUCD | Lucid Diagnostics Inc. | P — Open-market purchase | 245.0K | $1.00 | $245K |
| 2026-02-24 | LUCD | Lucid Diagnostics Inc. | A — Grant or award | 123.0K | $0.00 | |
| 2025-09-11 | DRIO | DarioHealth Corp. | A — Grant or award | 20.0K | $0.00 | |
| 2025-08-20 | LUCD | Lucid Diagnostics Inc. | P — Open-market purchase | 100.0K | $1.02 | $102K |
Matheis Dennis is a corporate insider — currently tracked as Director of Lucid Diagnostics Inc. (LUCD). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($347K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Matheis Dennis profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.